发明名称 GLP-1 RECEPTOR AGONISTS TO TREAT PANCREATITIS
摘要 The disclosure provides the use of GLP-1 receptor agonist compounds to treat pancreatitis (e.g., acute, chronic, hemorrhagic, necrotizing) in patients. The disclosure also provides the use of GLP-1 receptor agonist compounds to reduce elevated plasma amylase and/or lipase concentrations in patients. An exemplary GLP-1 receptor agonist compound is exenatide.
申请公布号 WO2011156407(A3) 申请公布日期 2012.04.26
申请号 WO2011US39494 申请日期 2011.06.07
申请人 AMYLIN PHARMACEUTICALS, INC.;TATARKIEWICZ, KRYSTYNA;PARKES, DAVID, G.;ROY, DENIS;GEDULIN, BRONISLAVA 发明人 TATARKIEWICZ, KRYSTYNA;PARKES, DAVID, G.;ROY, DENIS;GEDULIN, BRONISLAVA
分类号 A61K38/16 主分类号 A61K38/16
代理机构 代理人
主权项
地址
您可能感兴趣的专利